V005-7514 Screening compound: [4-(2-cyclohexyl-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-4-yl)piperazino](3,5-dimethoxyphenyl)methanone

V005-7514 Screening compound: [4-(2-cyclohexyl-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-4-yl)piperazino](3,5-dimethoxyphenyl)methanone
V005-7514 Screening compound: [4-(2-cyclohexyl-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-4-yl)piperazino](3,5-dimethoxyphenyl)methanone alternative view

Chemical Structure Depiction of ChemDiv screening compound V005-7514
[4-(2-cyclohexyl-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-4-yl)piperazino](3,5-dimethoxyphenyl)methanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V005-7514

Molecular Formula

C30H38N4O3S (C30 H38 N4 O3 S)

Compound Name

[4-(2-cyclohexyl-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-4-yl)piperazino](3,5-dimethoxyphenyl)methanone

IUPAC name

5-cyclohexyl-3-[4-(35-dimethoxybenzoyl)piperazin-1-yl]-8-thia-46-diazatricyclo[7.5.0.0^{27}]tetradeca-1(9)2(7)35-tetraene

SMILES

COc1cc(C(N(CC2)CCN2c2c(c(CCCCC3)c3s3)c3nc(C3CCCCC3)n2)=O)cc(OC)c1

InChI

InChI=1S/C30H38N4O3S/c1-36-22-17-21(18-23(19-22)37-2)30(35)34-15-13-33(14-16-34)28-26-24-11-7-4-8-12-25(24)38-29(26)32-27(31-28)20-9-5-3-6-10-20/h17-20H,3-16H2,1-2H3

InChI Key

AVBMCXMHGDOWCG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19852398

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

534.72

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

7.222

Distribution Coefficient, logD

6.556

Water Solubility, LogSw

-5.62

Polar Surface Area

55.016

Acid Dissociation Constant (pKa)

22.46

Base Dissociation Constant (pKb)

7.96

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

56.70

V005-7514 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V005-7514 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V005-7514?
Check Price and Availability of V005-7514, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V005-7514 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V005-7514
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V005-7514
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V005-7514 available by request